JP2025502614A5 - - Google Patents
Info
- Publication number
- JP2025502614A5 JP2025502614A5 JP2024533214A JP2024533214A JP2025502614A5 JP 2025502614 A5 JP2025502614 A5 JP 2025502614A5 JP 2024533214 A JP2024533214 A JP 2024533214A JP 2024533214 A JP2024533214 A JP 2024533214A JP 2025502614 A5 JP2025502614 A5 JP 2025502614A5
- Authority
- JP
- Japan
- Prior art keywords
- disorders
- pharmaceutically acceptable
- solvate
- acceptable salt
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163290037P | 2021-12-15 | 2021-12-15 | |
| US63/290,037 | 2021-12-15 | ||
| US202263387225P | 2022-12-13 | 2022-12-13 | |
| US63/387,225 | 2022-12-13 | ||
| PCT/US2022/052879 WO2023114320A1 (en) | 2021-12-15 | 2022-12-14 | Fused pyrrolidine psychoplastogens and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502614A JP2025502614A (ja) | 2025-01-28 |
| JP2025502614A5 true JP2025502614A5 (https=) | 2025-12-22 |
Family
ID=86773439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024533214A Pending JP2025502614A (ja) | 2021-12-15 | 2022-12-14 | 縮合ピロリジンサイコプラストゲンとその使用 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4448532A4 (https=) |
| JP (1) | JP2025502614A (https=) |
| KR (1) | KR20240150418A (https=) |
| AU (1) | AU2022415426A1 (https=) |
| CA (1) | CA3239571A1 (https=) |
| IL (1) | IL313457A (https=) |
| MX (1) | MX2024007220A (https=) |
| TW (1) | TW202333736A (https=) |
| WO (1) | WO2023114320A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023014630A (es) | 2021-06-08 | 2024-01-30 | Atai Therapeutics Inc | Activadores de dimetoxifenilalquilamina de receptores de serotonina. |
| IL313455A (en) | 2021-12-15 | 2024-08-01 | Delix Therapeutics Inc | Phenoxy and benzyloxy modified psychroplastogens and their uses |
| EP4457203A4 (en) | 2021-12-27 | 2025-12-17 | Atai Therapeutics Inc | AMINOTETRALINE ACTIVATORS OF SEROTONIN RECEPTORS |
| US12343319B2 (en) | 2023-05-01 | 2025-07-01 | Atai Therapeutics, Inc. | Compositions and methods for treatment of diseases and disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0808312T3 (da) * | 1995-02-02 | 2001-02-12 | Smithkline Beecham Plc | Indolderivater som 5-HT-receptorantagonist |
| AR023574A1 (es) * | 1999-04-23 | 2002-09-04 | Pharmacia & Upjohn Co Llc | Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios |
| WO2002024700A2 (en) * | 2000-09-20 | 2002-03-28 | Pharmacia & Upjohn Company | SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES |
| EP1632491A1 (en) * | 2004-08-30 | 2006-03-08 | Laboratorios Del Dr. Esteve, S.A. | Substituted indole compounds and their use as 5-HT6 receptor modulators |
| WO2021076572A1 (en) * | 2019-10-14 | 2021-04-22 | The Regents Of The University Of California | Ergoline-like compounds for promoting neural plasticity |
-
2022
- 2022-12-14 CA CA3239571A patent/CA3239571A1/en active Pending
- 2022-12-14 WO PCT/US2022/052879 patent/WO2023114320A1/en not_active Ceased
- 2022-12-14 JP JP2024533214A patent/JP2025502614A/ja active Pending
- 2022-12-14 MX MX2024007220A patent/MX2024007220A/es unknown
- 2022-12-14 KR KR1020247023489A patent/KR20240150418A/ko active Pending
- 2022-12-14 IL IL313457A patent/IL313457A/en unknown
- 2022-12-14 EP EP22908391.0A patent/EP4448532A4/en active Pending
- 2022-12-14 AU AU2022415426A patent/AU2022415426A1/en active Pending
- 2022-12-14 TW TW111148111A patent/TW202333736A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025502614A5 (https=) | ||
| JP5476371B2 (ja) | イソオキサゾール誘導体及び代謝型グルタミン酸受容体ポテンシエーターとしてのその使用 | |
| JP5871401B2 (ja) | ２−アリールイミダゾ［１，２−ａ］ピリジン−３−アセトアミド誘導体、その調製方法及び使用 | |
| JP2017524005A5 (https=) | ||
| JP2023513680A5 (https=) | ||
| JP2019532079A5 (https=) | ||
| JP2009542595A5 (https=) | ||
| JP2008513516A5 (https=) | ||
| RU2006101452A (ru) | Пиридазинил-пиперазины и их применение в качестве лигандов h3 гистаминового рецептора | |
| JP2010510237A5 (https=) | ||
| RU95113149A (ru) | Трициклические производные пиразола | |
| JP2003511434A (ja) | モノアミン再取込み阻害剤として有用な新規ビアリールエーテル誘導体 | |
| JP2006507220A5 (https=) | ||
| JP2013507355A (ja) | キサンチンオキシダーゼ阻害剤として効果的な新規化合物、その製造方法及びそれを含有する医薬組成物 | |
| JP2024516033A5 (https=) | ||
| JP2023535815A5 (https=) | ||
| JP2007502295A5 (https=) | ||
| JP2019530742A5 (https=) | ||
| JP2017502976A (ja) | １，２ナフトキノン誘導体及びその製造方法 | |
| JP2024508545A5 (https=) | ||
| JP2012526107A5 (https=) | ||
| JP2018531230A6 (ja) | 医薬化合物 | |
| JP2018531230A (ja) | 医薬化合物 | |
| JP2024542881A5 (https=) | ||
| JP2010531292A5 (ja) | １１−ピペラジン−１−イルジベンゾ[ｂ,ｆ][１,４]チアゼピンの誘導体及びその使用 |